Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · Real-Time Price · USD
1.630
+0.010 (0.62%)
Nov 21, 2024, 4:00 PM EST - Market closed
Biora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 6 | 37 | 29 | 374 | 296 | - | |
Market Cap Growth | -63.86% | 24.98% | -92.14% | 26.17% | - | - | |
Enterprise Value | 41 | 108 | 123 | 477 | 310 | - | |
Last Close Price | 1.62 | 13.50 | 32.92 | 522.50 | 1327.50 | - | |
PS Ratio | 5.48 | 9183.13 | 96.37 | 299.75 | 1828.75 | - | |
PB Ratio | -0.17 | -0.36 | -0.29 | -4.40 | -2.77 | - | |
EV/Sales Ratio | 46.36 | 26878.38 | 404.76 | 382.91 | 1910.59 | - | |
Debt / Equity Ratio | -0.36 | -0.47 | -1.27 | -1.49 | -1.52 | -0.87 | |
Asset Turnover | 0.04 | 0.00 | 0.00 | 0.01 | 0.00 | 1.32 | |
Inventory Turnover | - | - | - | - | - | 10.83 | |
Quick Ratio | 0.03 | 0.25 | 1.34 | 1.45 | 1.36 | 0.56 | |
Current Ratio | 0.05 | 0.30 | 1.64 | 1.60 | 1.74 | 0.74 | |
Return on Assets (ROA) | -154.63% | -99.04% | -47.56% | -55.95% | -52.51% | -80.30% | |
Return on Capital (ROIC) | - | - | -111.31% | -151.02% | -298.17% | -693.16% | |
Earnings Yield | -522.91% | -337.89% | -129.82% | -66.19% | -64.99% | - | |
FCF Yield | -766.03% | -132.31% | -221.86% | -45.04% | -57.25% | - | |
Buyback Yield / Dilution | -159.11% | -106.59% | -98.51% | -249.49% | -463.47% | -4.84% | |
Total Shareholder Return | -159.11% | -106.59% | -98.51% | -249.49% | -463.47% | -4.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.